Menu
Back to User profile » Prof. Dr. Hani Al-Salami
Papers published by Prof. Dr. Hani Al-Salami:
The Effects of Primary Unconjugated Bile Acids on Nanoencapsulated Pharmaceutical Formulation of Hydrophilic Drugs: Pharmacological Implications
Mooranian A, Foster T, Ionescu CM, Carey L, Walker D, Jones M, Wagle SR, Kovacevic B, Chester J, Johnstone E, Kuthubutheen J, Brown D, Atlas MD, Mikov M, Al-Salami H
Drug Design, Development and Therapy 2021, 15:4423-4434
Published Date: 23 October 2021
Bio Micro-Nano Technologies of Antioxidants Optimised Their Pharmacological and Cellular Effects, ex vivo, in Pancreatic β-Cells
Mooranian A, Zamani N, Mikov M, Goločorbin-Kon S, Stojanovic G, Arfuso F, Kovacevic B, Al-Salami H
Nanotechnology, Science and Applications 2020, 13:1-9
Published Date: 7 January 2020
An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer
Mooranian A, Negrulj R, Chen-Tan N, Watts GF, Arfuso F, Al-Salami H
Drug Design, Development and Therapy 2014, 8:1673-1683
Published Date: 29 September 2014
Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol
Mooranian A, Negrulj R, Chen-Tan N, Al-Sallami HS, Fang Z, Mukkur TK, Mikov M, Golocorbin-Kon S, Fakhoury M, Watts GF, Matthews V, Arfuso F, Al-Salami H
Drug Design, Development and Therapy 2014, 8:1221-1230
Published Date: 9 September 2014
Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study
Mooranian A, Negrulj R, Chen-Tan N, Al-Sallami HS, Fang Z, Mukkur T, Mikov M, Golocorbin-Kon S, Fakhoury M, Arfuso F, Al-Salami H
Drug Design, Development and Therapy 2014, 8:1003-1012
Published Date: 28 July 2014
Inflammatory bowel disease: clinical aspects and treatments
Fakhoury M, Negrulj R, Mooranian A, Al-Salami H
Journal of Inflammation Research 2014, 7:113-120
Published Date: 23 June 2014